Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-interventional Clinical Study to Observe Improvement in Global Assessment of Functioning in Patients With Schizophrenia, Treated With Atypical Antipsychotics

NCT00833456 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00833456
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00833456 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-interventional Clinical Study to Observe Improvement in Global Assessment of Functioning in Patients With Schizophrenia, Treated With Atypical Antipsychotics
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
February 28, 2009
Completion date
November 30, 2010
Enrollment
106 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia